Skip to main content

Table 1 Clinical and tumor characteristics of 138 patients

From: Risk factors for early progression of diffuse low-grade glioma in adults

Variable

Recurrence (n = 80)

Non-recurrence (n = 58)

Sex, n (%)

 Male

39 (48.8)

28 (48.3)

 Female

41 (51.2)

30 (51.7)

Age, years, n (%)

 ≥ 40

38 (47.5)

28 (48.3)

 < 40

42 (52.5)

30 (51.7)

Tumor subtype, n (%)

 Astrocytoma

59 (73.8)

35 (60.3)

 Oligodendroglioma

21 (26.2)

23 (39.7)

Tumor location, n (%)

 Superfical

60 (75.0)

47 (81.0)

 Deep

20 (25.0)

11 (19.0)

Tumor range, n (%)

 Single lobe

45 (56.3)

33 (56.9)

 Multiple lobe

35 (43.7)

25 (43.1)

Preoperative tumor volume, cm3, n (%)

 ≤ 30

26 (32.5)

29 (50.0)

 > 30

54 (67.5)

29 (50.0)

EOR, n (%)

 100

36 (45.0)

26 (44.8)

 90–100

32 (40.0)

24 (41.4)

 < 90

12 (15.0)

8 (13.8)

Treatment after first surgery, n (%)

 RT alone

20 (25.0)

0 (0.0)

 Chemotherapy alone

16 (20.0)

9 (15.5)

 RT + chemotherapy

26 (32.5)

34 (58.6)

 None

18 (22.5)

15 (25.9)

  1. EOR extent of resection, RT radiotherapy